Tyrosine Kinase Receptor
Also known as: Receptor tyrosine kinase, RTK, Tyrosine kinase receptor
Tyrosine Kinase Receptor is a type of cell surface receptor that phosphorylates tyrosine residues on target proteins to initiate signaling cascades when activated by growth factors, hormones, or cytokines. These receptors play crucial roles in cell growth, differentiation, metabolism, and survival, making them important targets in cancer and metabolic research.
Last updated: February 1, 2026
How Tyrosine Kinase Receptors Work
Unlike GPCRs that use G-proteins, tyrosine kinase receptors have intrinsic enzymatic activity. When activated, they directly phosphorylate target proteins:
- Ligand binding - Growth factor or hormone binds to extracellular domain
- Dimerization - Two receptor molecules come together
- Autophosphorylation - Receptors phosphorylate each other’s tyrosine residues
- Docking site creation - Phosphotyrosines create binding sites for signaling proteins
- Cascade activation - Downstream pathways are activated (Ras/MAPK, PI3K/Akt)
- Cellular response - Changes in gene expression, metabolism, growth
Key Tyrosine Kinase Receptors in Peptide Research
Insulin Receptor
The most relevant RTK for metabolic peptide research:
- Ligand: Insulin
- Key pathways: PI3K/Akt (glucose uptake), Ras/MAPK (growth)
- Function: Glucose metabolism, protein synthesis, fat storage
- Clinical relevance: Type 2 diabetes, metabolic syndrome
IGF-1 Receptor
Closely related to insulin receptor:
- Ligand: IGF-1 (insulin-like growth factor 1)
- Key pathways: PI3K/Akt, Ras/MAPK
- Function: Cell growth, tissue repair, muscle development
- Clinical relevance: Growth disorders, aging research
Other Important RTKs
| Receptor | Ligand | Primary Function |
|---|---|---|
| EGFR | EGF, TGF-alpha | Cell proliferation |
| VEGFR | VEGF | Blood vessel formation |
| PDGFR | PDGF | Wound healing, development |
| FGFR | FGF family | Development, tissue repair |
RTK Signaling Pathways
Growth Factor binds receptor
↓
Receptor Dimerization
↓
Autophosphorylation
↓
┌────┴────┐
↓ ↓
Ras/MAPK PI3K/Akt
Pathway Pathway
↓ ↓
Cell Metabolism
Growth Survival
Ras/MAPK Pathway
- Controls cell proliferation and differentiation
- Activates transcription factors for growth genes
- Dysregulation linked to cancer
PI3K/Akt Pathway
- Controls metabolism, glucose uptake, protein synthesis
- Promotes cell survival
- Key pathway for insulin action
RTKs vs GPCRs
| Feature | RTKs | GPCRs |
|---|---|---|
| Signaling mechanism | Direct phosphorylation | G-protein cascade |
| Response speed | Slower (minutes) | Fast (seconds) |
| Duration | Longer lasting | Shorter |
| Typical ligands | Growth factors | Hormones, peptides |
| Main effects | Growth, metabolism | Secretion, neural |
Clinical Relevance
Insulin Resistance
When insulin receptors don’t respond properly:
- Receptor downregulation (fewer receptors)
- Impaired tyrosine kinase activity
- Defective downstream signaling
- Result: Type 2 diabetes, metabolic syndrome
GH/IGF-1 Axis
Growth hormone works partly through RTK signaling:
- GH stimulates IGF-1 production in liver
- IGF-1 activates IGF-1 receptor (RTK)
- Produces anabolic effects on muscle and bone
- Research peptides like GHRP-6 increase GH to stimulate this axis
Frequently Asked Questions
How do tyrosine kinase receptors differ from other receptors?
They have built-in enzyme activity. When activated, they directly add phosphate groups to tyrosine amino acids on target proteins. This is different from GPCRs, which work through intermediate G-proteins, and from nuclear receptors, which directly bind DNA.
Why is the insulin receptor important for understanding peptides?
Insulin and IGF-1 are themselves peptides that work through RTKs. Additionally, many other peptides (like GH secretagogues) ultimately affect RTK signaling indirectly by changing levels of insulin or IGF-1. Understanding RTKs helps explain metabolic effects of various peptides.
Can RTK activity be enhanced therapeutically?
Most RTK drugs are inhibitors (used in cancer). However, research explores ways to sensitize RTKs, particularly the insulin receptor, to treat insulin resistance. Some peptide research aims to enhance GH/IGF-1 signaling to improve metabolic function.
Related Terms
Disclaimer: This glossary entry is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for medical questions.